The data showed elevated levels of the metabolite αKG improved DNA repair, and blocking it made the cancer cells more sensitive to treatment.

Researchers developed PRINCE, a small-molecule-controlled CRISPR system enabling precise, long-term regulation of gene editing.

The latest update to the ESM protein language model series supports binder design and protein function mapping for therapeutic discovery.

Researchers suggest MutationProjector offers a unifying framework for connecting tumor genotypes to biological mechanisms and therapeutic outcomes.

Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up-to-$3.83 billion cash, in deals intended to expand the acquisitive pharma giant’s ...

By developing their own functional nerves, these organoids demonstrate how engineering principles can drive biological ...

Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets ...

Regeneron Pharmaceuticals will partner with Parabilis Medicines to discover and develop an initial five candidates ...

Roughly 2700 attendees heard a range of perspectives from experts in precision medicine, bioinformatics, and rare disease ...

Biotech companies that use CDD Vault will be able to utilize select Lilly predictive models within their natural scientific ...

Researchers say epigenetic phase variation mechanism may explain microbiome resilience and variability and could guide the ...

New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity.